| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| North and South America (excluding U.S) | 14.6 | 6.9 | 8.2 | | | | | |
| U.S. government | 113.7 | 31.6 | | | | | | |
| U.S. sales | 53.9 | 42.2 | 31.9 | 28.6 | 27.0 | | | |
| Other | 6.3 | 1.2 | 1.7 | 4.6 | 7.5 | | | |
| Total revenues | 188.4 | 81.9 | 41.8 | 33.3 | 34.5 | 29.8 | 29.6 | 34.5 |
| Revenue growth [+] | 130.1% | 95.9% | 25.6% | -3.5% | 15.6% | 0.9% | -14.4% | 12.1% |
| North and South America (excluding U.S) | 111.2% | -16.4% | | | | | | |
| U.S. government | 259.3% | | | | | | | |
| U.S. sales | 27.8% | 32.2% | 11.3% | 6.0% | | | | |
| North and South America sales (excluding U.S.) | | | | -43.6% | | | | 26.9% |
| Cost of goods sold | 93.0 | 44.9 | 27.7 | 23.1 | 24.5 | 19.5 | 19.0 | 22.5 |
| Gross profit | 95.4 | 37.0 | 14.1 | 10.2 | 10.0 | 10.3 | 10.6 | 12.0 |
| Gross margin | 50.6% | 45.2% | 33.8% | 30.7% | 28.9% | 34.7% | 35.8% | 34.8% |
| Selling, general and administrative [+] | 21.9 | 12.4 | 10.7 | 11.2 | 13.0 | 12.8 | 13.2 | 13.6 |
| Sales and marketing | 4.5 | 4.1 | 4.2 | 4.4 | 4.7 | 4.0 | 3.8 | 4.0 |
| General and administrative | 17.4 | 8.3 | 6.4 | 6.8 | 8.4 | 8.8 | 9.3 | 9.6 |
| Research and development | 0.9 | 0.6 | 0.5 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 |
| Other operating expenses | | | | -0.3 | | | -7.7 | |
| EBITDA [+] | 73.9 | 24.9 | 3.8 | -0.4 | -2.9 | -2.2 | 5.4 | -1.1 |
| EBITDA growth | 196.6% | 551.2% | -963.7% | -85.0% | 35.2% | -140.5% | -596.3% | -76.7% |
| EBITDA margin | 39.2% | 30.4% | 9.1% | -1.3% | -8.5% | -7.3% | 18.2% | -3.1% |
| Depreciation and amortization | 1.3 | 0.8 | 0.9 | 0.9 | 0.8 | 0.9 | 0.9 | 1.1 |
| EBIT [+] | 72.6 | 24.1 | 3.0 | -1.3 | -3.8 | -3.1 | 4.5 | -2.2 |
| EBIT growth | 201.6% | 710.0% | -323.5% | -64.8% | 23.9% | -167.5% | -309.4% | -63.6% |
| EBIT margin | 38.5% | 29.4% | 7.1% | -4.0% | -11.0% | -10.2% | 15.3% | -6.3% |
| Non-recurring items [+] | | | | | | 0.5 | 7.7 | |
| Asset impairment | | | | | | 0.5 | | |
| Legal settlement | | | | | | | 7.7 | |
| Interest expense, net [+] | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Interest expense | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Interest income | | | | | | | | 0.0 |
| Other income (expense), net [+] | 2.6 | 2.3 | 0.4 | 0.2 | 0.1 | 0.0 | 7.7 | |
| Gain (loss) on debt retirement | 1.4 | | | | | | | |
| Pre-tax income | 75.0 | 26.1 | 3.2 | -1.4 | -3.9 | -3.7 | 4.3 | -2.3 |
| Income taxes | 18.9 | 1.9 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 |
| Tax rate | 25.2% | 7.1% | 0.2% | 1.0% | 4.8% | | 0.2% | |
| Net income | 55.8 | 26.6 | 2.4 | -2.0 | -4.4 | -4.4 | 5.9 | -3.3 |
| Net margin | 29.6% | 32.5% | 5.9% | -6.1% | -12.9% | -14.8% | 20.0% | -9.5% |
| |
| Basic EPS [+] | $1.65 | $0.80 | $0.07 | ($0.06) | ($0.14) | ($0.15) | $0.21 | ($0.12) |
| Growth | 105.3% | 972.4% | -219.6% | -55.0% | -7.3% | -170.6% | -277.9% | -54.8% |
| Diluted EPS [+] | $1.63 | $0.80 | $0.07 | ($0.06) | ($0.14) | ($0.15) | $0.20 | ($0.12) |
| Growth | 103.9% | 968.1% | -219.6% | -55.0% | -7.3% | -174.8% | -267.9% | -54.8% |
| |
| Shares outstanding (basic) [+] | 33.9 | 33.2 | 32.7 | 32.7 | 32.0 | 29.4 | 27.8 | 27.4 |
| Growth | 2.1% | 1.5% | 0.0% | 2.2% | 8.9% | 5.5% | 1.6% | 1.4% |
| Shares outstanding (diluted) [+] | 34.2 | 33.3 | 32.7 | 32.7 | 32.0 | 29.4 | 29.5 | 27.4 |
| Growth | 2.8% | 1.9% | 0.0% | 2.2% | 8.9% | -0.4% | 7.7% | 1.4% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |